The market for home infusion services is approaching $10 billion annually. The amount is split almost evenly between reimbursement for drug product and for the services pharmacists provide in preparing, delivering, and supporting home IV therapy.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.